CURRICULUM VITAE Eric J. Lenze, M.D. - Institute for Public Health
CURRICULUM VITAE Eric J. Lenze, M.D. - Institute for Public Health CURRICULUM VITAE Eric J. Lenze, M.D. - Institute for Public Health
47. “New treatment targets for late-life depression and anxiety disorders”, ECNP annual meeting, Paris, September 2011. 48. “Treating stress and improving cognition in older adults”, Department of Aging, University of Florida, September 2011. 49. “Anxiety disorders”, Geriatric Psychiatry review course, AAGP annual meeting, Washington DC, March 2012 50. “Enhanced medical rehabilitation”, AAGP annual meeting, Washington DC, March 2012. 51. “Developing new rehabilitation interventions”, Rehabilitation Research Network keynote speaker, Pittsburgh, PA May 2012. 52. “Cognitive dysfunction: the symptom of depression that nobody understands”, ECNP annual meeting, Vienna, October 2012 CONSULTING RELATIONSHIPS AND BOARD MEMBERSHIPS 2004-2005: Board, American Association of Clinical Psychiatrists 2005-2011: Co-chair, Research Committee, American Association for Geriatric Psychiatry 2011: Program Chair, American Association for Geriatric Psychiatry 2011-present: Chair, Research Committee, American Association for Geriatric Psychiatry 2005-present: Member and chair (2006-present) of Data and Safety Monitoring Board for AgeWise and AgeWise II programs (NIA-sponsored program grants), University of Pittsburgh 2007-2011: Consultant, Fox Learning Systems (small business) 2008-present: Scientific Council, Anxiety Disorders Association of America 2009-present: DSM-V lifespan committee; head of workgroup on anxiety disorders and aging 2010-present: Chair, Data and Safety Monitoring Board for DASH (NHLBI) study (Ken Freedland, PI), Washington University 2011-present: Chair, DSM-V lifespan committee Governmental: RESEARCH SUPPORT Role Years Grant Title and role Past Funding: PI 1999 Seed money grant: Combination pharmacotherapy of depressed elderly patients in acute rehabilitation (PI) Source and amount Internal $10,000 PI 2001- 2006 K23 MH64196: Depression Treatment in Medically Rehabilitating Elderly NIMH $848,933 6
Consultant 2008- 2010 Co-I 2004- 2009 PI 2004- 2010 SBIR Phase 2: Web-based stroke health education (PI: Debra Fox, Fox Learning Systems) R01 MH059395: Improving Quality of Primary Care for Anxiety Disorders (PI: Bruce Rollman, MD) R01 MH070547: Pharmacotherapy of Late Life Generalized Anxiety Disorder NINDS NIMH NIMH $1,365,000 PI 2009- 2011 R34 MH083868 Enhanced Acute Medical Rehabilitation for Late-Life Depression After Hip Fracture NIMH $684,000 PI 2010- 2011 R01 MH074596S Supplement to Risk Genes for Late Life Depression After Hip Fracture NIMH $63,840 Current Funding: PI 2007- 2012 R01 MH074596 Risk Genes for Late Life Depression After Hip Fracture NIMH $1,686,938 PI 2009- 2014 R01 MH083648 Incomplete Response in Late-Life Depression: Getting to Remission NIMH $2,143,501 coordinating site PI 2011- 2014 Collaborative R34 Mindfulness-Based Stress Reduction and Cognitive Function in Stress and Aging NCCAM $602,000 Consultant 2009- 2013 R01HD055525 Donepezil to Promote Functional Recovery Post-Stroke (PI: Ellen Whyte, MD) NICHD Non-governmental: Role Years Grant Title and role Source and amount Past Funding: PI 2000 Investigator-initiated project: Treatment of anxiety disorders in elderly subjects: a controlled study with citalopram PI 2003 Investigator-initiated project: Galantamine for the Treatment of Post-Stroke Cognitive Impairment in the PI 2004- 2005 PI 2006- 2008 PI 2007 Medical Rehabilitation Setting Investigator-initiated project: Donepezil for the Treatment of Post-Stroke Cognitive Impairment in the Medical Rehabilitation Setting Investigator-initiated project: Memantine for the enhancement of rehabilitation efficacy and prevention of major depressive disorder in older adults A multi-center, open-label study in healthy volunteers and patients with affective and anxiety disorders to characterize the regional distribution of [ 11 C] ABP688 in brain by PET Forest Laboratories $97,175 Janssen Pharmaceuticals $90,000 Pfizer Pharmaceuticals $68,000 Forest Laboratories $149,884 Novartis $482,123 Current Funding: 7
- Page 1 and 2: 3/26/13 CURRICULUM VITAE Eric J. Le
- Page 3 and 4: Reviewer for Acta Psychiatrica Scan
- Page 5: elderly”, APA annual meeting, Tor
- Page 9 and 10: Courses: 1. Course Name: Descriptio
- Page 11 and 12: 14. Course Name: Description: Year:
- Page 13 and 14: 26. Course Name: Description: Year:
- Page 15 and 16: Peer-Reviewed Original Research Art
- Page 17 and 18: 29. Munin MC, Begley AE, Skidmore E
- Page 19 and 20: 57. Karp JF, Dew MA, Houck PR, Lotz
- Page 21 and 22: 4. Lenze EJ, Holm MB, Rogers JC, Re
- Page 23: 7. Lenze EJ. The treatment of late-
47. “New treatment targets <strong>for</strong> late-life depression and anxiety disorders”, ECNP annual meeting,<br />
Paris, September 2011.<br />
48. “Treating stress and improving cognition in older adults”, Department of Aging, University of<br />
Florida, September 2011.<br />
49. “Anxiety disorders”, Geriatric Psychiatry review course, AAGP annual meeting, Washington<br />
DC, March 2012<br />
50. “Enhanced medical rehabilitation”, AAGP annual meeting, Washington DC, March 2012.<br />
51. “Developing new rehabilitation interventions”, Rehabilitation Research Network keynote<br />
speaker, Pittsburgh, PA May 2012.<br />
52. “Cognitive dysfunction: the symptom of depression that nobody understands”, ECNP annual<br />
meeting, Vienna, October 2012<br />
CONSULTING RELATIONSHIPS AND BOARD MEMBERSHIPS<br />
2004-2005: Board, American Association of Clinical Psychiatrists<br />
2005-2011: Co-chair, Research Committee, American Association <strong>for</strong> Geriatric Psychiatry<br />
2011: Program Chair, American Association <strong>for</strong> Geriatric Psychiatry<br />
2011-present: Chair, Research Committee, American Association <strong>for</strong> Geriatric Psychiatry<br />
2005-present: Member and chair (2006-present) of Data and Safety Monitoring Board <strong>for</strong> AgeWise<br />
and AgeWise II programs (NIA-sponsored program grants), University of Pittsburgh<br />
2007-2011: Consultant, Fox Learning Systems (small business)<br />
2008-present: Scientific Council, Anxiety Disorders Association of America<br />
2009-present: DSM-V lifespan committee; head of workgroup on anxiety disorders and aging<br />
2010-present: Chair, Data and Safety Monitoring Board <strong>for</strong> DASH (NHLBI) study (Ken Freedland, PI),<br />
Washington University<br />
2011-present: Chair, DSM-V lifespan committee<br />
Governmental:<br />
RESEARCH SUPPORT<br />
Role Years Grant Title and role<br />
Past Funding:<br />
PI 1999 Seed money grant: Combination pharmacotherapy of<br />
depressed elderly patients in acute rehabilitation (PI)<br />
Source and<br />
amount<br />
Internal<br />
$10,000<br />
PI 2001-<br />
2006<br />
K23 MH64196: Depression Treatment in Medically<br />
Rehabilitating Elderly<br />
NIMH<br />
$848,933<br />
6
Change language